AstraZeneca (AZNL)

13,836.00p
   
  • Change Today:
    -195.00p
  • 52 Week High: 14,292.00p
  • 52 Week Low: 9,642.00p
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 17,309
  • Market Cap: £174,910m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Sep-25 Q3 15,191.00 3,244.00 164.00¢ n/a

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 26,617.00 3,916.00 244.00¢ 41.2 0.3 +137% 280.00¢ 2.8%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,481.8 n/a -97% 287.00¢ 2.4%
31-Dec-22 44,351.00 2,501.00 212.00¢ 72.6 0.0 +2,550% 290.00¢ 1.9%
31-Dec-23 45,811.00 6,899.00 726.00¢ 20.0 0.1 +242% 290.00¢ 2.0%
31-Dec-24 54,073.00 8,691.00 821.00¢ 17.4 1.3 +13% 310.00¢ 2.2%

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 58,643.47 18,255.25 654.60p 21.4 2.3 +9% 236.66p 0.0%
31-Dec-26 62,148.64 20,298.70 736.42p 19.1 1.5 +12% 248.88p 0.0%
31-Dec-27 65,886.27 22,242.54 822.18p 17.1 1.5 +12% 259.18p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 41.10 15.94 320.56 0.07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 13,836.00p
Change Today -195.00p
% Change -1.39 %
52 Week High 14,292.00p
52 Week Low 9,642.00p
Volume 17,309
Shares Issued 1,264.16m
Market Cap £174,910m

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 03-Feb-2026

Time Volume / Share Price
08:10 80 @ 13,836.00p
08:10 17 @ 13,836.00p
08:10 6 @ 13,841.28p
08:10 7 @ 13,841.36p
08:10 50 @ 13,834.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page